It has been implicated in the progression of a variety of tumors; most brain tumors showed constitutively elevated levels of COX-2 and among them GBM tumors, where COX-2 was upregulated mostly in central, hypoxic regions of the tumor [66]. The gene discussed is PTGS2; the disease is neoplasm.